Osteoporosis Home > Avesta
Were you looking for information on Evista? Avesta is a common misspelling of Evista.
Evista® is approved to treat and prevent osteoporosis in postmenopausal women, as well as to reduce the risk of breast cancer in postmenopausal women, whether they have osteoporosis or not. The drug has two primary effects: it binds to estrogen receptors in the breast and increases bone mineral density. In one study, the drug reduced the risk of breast cancer by up to 44 percent in postmenopausal women without osteoporosis who were at high risk for breast cancer.
Evista comes in tablet form and is typically taken once a day. There is only one standard recommended dosage, regardless of your age, weight, or other medical conditions or medications. In addition, the dose is the same regardless of whether you are using it for osteoporosis or for preventing breast cancer. Most people tolerate the medication well, but side effects are possible. Some of the common side effects of Evista include hot flashes, joint pain, and flu-like symptoms.
(Click Evista to learn more, including how the drug is able to treat and prevent both osteoporosis and breast cancer, additional side effects, and things to tell your healthcare provider before starting treatment. You can also click on the links in the box to the right for more specific topics on Evista.)